NCT06993896Not yet recruiting
Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer
Assessment of Physical Activity During Chemo- and/or Immunotherapy for Lung Cancer
Source: ClinicalTrials.gov · Last updated 29 May 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main goal of this trial is to describe the pattern of physical activity in patients with non-small cell lung cancer during chemo- and/or immunotherapy, to evaluate potential predictors of those patterns and to assess potential correlations with patient reported outcomes (pain-, distress-, and fatigue scores). To reach this goal, this trial will be first trial in which the mean number of steps per week performed at baseline and during each week of chemo- and or immunotherapy will be collected in a standardized prospective way. The trial is exploratory in nature with the aim to generate scientific hypotheses to be investigated in future clinical trials.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 38 (estimated)
- First submitted
- 16 May 2025
- Start date
- 16 Jun 2025
- Primary completion date
- 30 Nov 2025
- Lead sponsor
- University Hospital Schleswig-Holstein
- Diseases
- Lung cancer
- NCT number
- NCT06993896
What you commit to
- Study type: Observational
- Planned participants: 38
- From 16 Jun 2025 to the primary completion date, 30 Nov 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Thoracic surgery within 3 months prior to chemo- and/or immunotherapy
Other illness
- Small-cell lung cancer
Other
- Karnofsky performance score \<60
- Expected Non-Compliance
Who the study is looking for
- Histologically proven non-small cell lung cancer
- Indication for chemo- and/or immunotherapy
- Possession of and ability to use a smart phone that includes a step counter
- Willingness to wear the smart phone close to the body at any time
- Age ≥18 years
- Written informed consent
- Capacity of the patient to consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.